Neupro (UCB, Inc.)
Welcome to the PulseAid listing for the Neupro drug offered from UCB, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | UCB, Inc. |
| NON-PROPRIETARY NAME: | rotigotine |
| SUBSTANCE NAME: | ROTIGOTINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | TRANSDERMAL |
| DOSAGE FORM: | PATCH, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2012-04-02 |
| END MARKETING DATE: | 0000-00-00 |
Neupro HUMAN PRESCRIPTION DRUG Details:
| Item Description | Neupro from UCB, Inc. |
| LABELER NAME: | UCB, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1(mg/24h) |
| START MARKETING DATE: | 2012-04-02 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 50474-801_0bb12d38-8fec-4b7f-8bfa-87ba7014a464 |
| PRODUCT NDC: | 50474-801 |
| APPLICATION NUMBER: | NDA021829 |
Other ROTIGOTINE Pharmaceutical Manufacturers / Labelers:
